Table 1.
Participant demographics
| Listener | Sex | Age | Ear T ested | Implantation | Hearing Loss Type | Hearing Loss Etiology | 1st Ear Implanted | 1st Device | Age at 1st Activation (months) | 2nd Ear Implanted | 2nd Device | Age at 2nd Activation (months) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C1 | F | 16 | Right | Bilateral | Congenital, bilateral | Prematurity | Right | AB | 11 | Lett | AB | 47 |
| C2 | F | 8 | Right | Bilaterali† | Congenital, bilateral | Unknown | Right | Cochlear | 9 | Left | Cochlear | 9 |
| C3 | M | 11 | Right | Bilateral | Congenital, bilateral | Unknown | Right | Cochlear | 12 | Left | Cochlear | 20 |
| C4 | F | 5 | Right | Bilateral | Congenital, bilateral | Unknown | Right | Cochlear | 14 | Left | Cochlear | 39 |
| C5 | M | 10 | Right | Bilateral | Congenital, bilateral | EVA | Right | Cochlear | 17 | Left | Cochlear | 38 |
| C6 | F | 11 | Right | Bilateral | Congenital, bilateral | Unknown | Right | Cochlear | 9 | Left | Cochlear | 14 |
| C7 | F | 13 | Right | Bilateral | Congenital, bilateral | Unknown | Right | Cochlear | 13 | Left | Cochlear | 41 |
| C8 | M | 9 | Right | Bilateral | Congenital, bilateral | Genetic, non-syndromic | Left | Cochlear | 9 | Right | Cochlear | 18 |
| C9 | M | 11 | Left | Bilateral | Congenital, bilateral | Unknown | Left | Cochlear | 24 | Right | Cochlear | 48 |
| C10 | F | 5 | Left | Unilateral | Congenital, bilateral | Unknown | Left | Cochlear | 19 | NA | NA | NA |
| C11 | M | 6 | Left | Bilateral | Congenital, bilateral | Unknown | Left | Cochlear | 12 | Right | Cochlear | 18 |
| C12 | M | 13 | Left | Bilateral | Sudden, bilateral | Ototoxicity | Right | Cochlear | 15 | Left | Cochlear | 38 |
| C13 | M | 8 | Left | Bilateral | Congenital, bilateral | Unknown | Left | Cochlear | 18 | Right | Cochlear | 31 |
| C14 | M | 6 | Right | Bilateral† | Congenital, bilateral | Genetic, non-syndromic | Right | Cochlear | 12 | Left | Cochlear | 12 |
| C15 | M | 8 | Right | Bilateral† | Congenital, bilateral | Genetic, non-syndromic | Right | AB | 16 | Left | AB | 16 |
| Listener | Sex | Age | Ear Tested | Implantation | Hearing Loss Type | Hearing Loss Etiology | 1st Ear Implanted | 1st Device | Age at 1st Activation (years) | 2nd Ear Implanted | 2nd Device | Age at 2nd Activation (years) |
|
| ||||||||||||
| A1 | M | 56 | Right | Bilateral | Congenital, bilateral | Rubella | Left | Med-El | 36 | Right | Med-El | 44 |
| A2 | M | 51 | Right | Unilateral | Progressive bilateral | Genetic, non-syndromic | Right | AB | 45 | NA | NA | NA |
| A3 | F | 73 | Right | Bilateral | Congenital, bilateral | Unknown | Left | Cochlear | 55 | Right | Cochlear | 61 |
| A4 | F | 57 | Right | Bilateral | Progressive, bilateral | Ototoxicity | Left | AB | 45 | Right | AB | 47 |
| A5 | F | 21 | Right | Unilateral | Congenital, bilateral | Genetic, non-syndromic | Right | Cochlear | 10 | NA | NA | NA |
| A6 | M | 64 | Right | Unilateral | Unknown | Ototoxicity | Right | Cochlear | 63 | NA | NA | NA |
| A7 | F | 76 | Left | Unilateral | Progressive, bilateral | Genetic, non-syndromic | Left | Cochlear | 70 | NA | NA | NA |
| A8 | F | 76 | Right | Bilateral | Progressive, bilateral | Genetic, non-syndromic | Right | Cochlear | 50 | Left | Cochlear | 63 |
| A9 | M | 82 | Left | Unilateral | Progressive, bilateral | Unknown | Left | Cochlear | 68 | NA | NA | NA |
| A10 | M | 73 | Right | Unilateral | Progressive, bilateral | Other | Right | Cochlear | 70 | NA | NA | NA |
| A11 | F | 73 | Right | Unilateral | Progressive, bilateral | Unknown | Right | AB | 70 | NA | NA | NA |
| A12 | F | 56 | Right | Unilateral | Progressive, unilateral | Genetic, Waardenburg | Right | Med-El | 54 | NA | NA | NA |
| A13 | M | 73 | Right | Unilateral | Progressive, bilateral | Genetic, non-syndromic | Right | AB | 71 | NA | NA | NA |
Note: AB = Advanced Bionics, EVA = Enlarged vestibular aqueduct
†
Implanted simultaneously